![]() Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | CellPly CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment. | Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. | ||
Founding Date | Founding Date 2004 | Founding Date 2013 | Founding Date 2013 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations HQ | Locations Austin, US HQ | Locations Bologna, IT HQ Bologna, IT | Locations Newark, US HQ |
Employees | Employees 517% decrease | Employees 65117% increase | Employees 313% decrease | Employees 6343% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) N/A | Valuation ($) 44 m |
Financial | ||||
Net income | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income N/A | Net income ($75.7m) (FY, 2022) |
Funding | ||||
Latest funding round | Latest funding round $ 30.8m (about 5 years ago) | Latest funding round N/A | Latest funding round $ 341.6k (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 41.2m | Total funding raised N/A | Total funding raised $ 5.9m | Total funding raised $ 82.4m |

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyCellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment.
View companyRain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View company